| abstract |
The present invention relates to a pharmaceutical formulation of odevixibat, for example a pediatric formulation, comprising a plurality of small particles. The present formulation can be used for the treatment of liver diseases such as bile acid dependent liver disease, in particular biliary identity liver disease, such as biliary atresia, progressive familial intrahepatic cholestasis (PFIC), allagil syndrome (ALGS) and biliary identity itching in children. . The invention also relates to a method of making a pharmaceutical formulation. |